Pyrroles
Medchemexpress LLC HY-B0580A 5mg Medchemexpress, (S)-Ketorolac CAS:66635-92-5 Purity:>98%
Medchemexpress, HY-B0580A 5mg (S)-Ketorolac CAS:66635-92-5 (S)-Ketorolac is a nonsteroidal anti-inflammatory agent. (S)-ketorolac exhibits potent COX1 and COX2 enzyme inhibition [1] . Purity:>98% Medchemexpress has over 10000 novel life-science reagents, reference compounds, APIs and natural compounds for laboratory and scientific use. Other quantity can also be offered.
eMolecules 851376-05-1 | Medchem Express | JNJ-18038683 | 5mg | 506404111 | HY-19889 | 529.97 | C26H28ClN3O7
Medchem Express | JNJ-18038683 | 5mg | 506404111 | HY-19889 | 851376-05-1 | 529.970 | C26H28ClN3O7
Medchemexpress LLC HY-11011 10mg Medchemexpress, A-770041 CAS:869748-10-7 Purity:>98%
Medchemexpress, HY-11011 10mg A-770041 CAS:869748-10-7 Purity:>98% Medchemexpress has over 10000 novel life-science reagents, reference compounds, APIs and natural compounds for laboratory and scientific use. Other quantity can also be offered.
Medchemexpress LLC CB-5083 | 1542705-92-9 | MFCD28963914 | 5mg
CB-5083 | Purity: 99.95% | MW: 413.479 | 1542705-92-9 | MFCD28963914 | 5mg
Medchemexpress LLC TRILACICLIB HYDROCHLORIDE 10MG
Trilaciclib hydrochloride (Synonyms: G1T28 hydrochloride) 10mgCAS #1977495-97-8
Medchemexpress LLC Entasobulin | 501921-61-5 | 98.5% | 439.89 | 50 MG
Entasobulin is a β-tubulin polymerization inhibitor with potential anticancer activity. It is an indolizine-glyoxylamide based small molecule that demonstrates substantial in vitro anti-proliferative activities against cancer cell lines, including multidrug resistance (MDR) phenotypes.
- Inhibits β-tubulin polymerization
- Shows potential anticancer activity
- Demonstrates substantial in vitro anti-proliferative activities against cancer cell lines
- Effective against multidrug resistance (MDR) phenotypes
- For research use only
Medchemexpress LLC Pevonedistat | 905579-51-3 | 99.98% | C21H25N5O4S | 200 MG
Pevonedistat (MLN4924) is a potent and selective NEDD8-activating enzyme (NAE) inhibitor. It acts by inducing deregulation of S-phase DNA synthesis, which disrupts protein turnover mediated by cullin-RING ligase, ultimately leading to apoptosis in human tumor cells. It also suppresses the growth of human tumor xenografts in mice.
- Potent and selective NEDD8-activating enzyme (NAE) inhibitor
- Induces deregulation of S-phase DNA synthesis
- Disrupts protein turnover mediated by cullin-RING ligase
- Promotes apoptosis of human tumor cells
- Suppresses tumor xenograft growth in mice
eMolecules 213743-31-8 | Medchem Express | RK-24466 | 5mg | 437899035 | HY-108318 | MFCD04974490 | 370.456 | C23H22N4O
ChemScene | (S)-2-Amino-5-(isopropylamino)-5-oxopentanoic acid | 250mg | 628857491 | CS-0186170 | 4311-12-0 | MFCD00672360 | 188.227 | C8H16N2O3
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool<|a>
Medchemexpress LLC 5-hydroxy-3-(indol-3-yl)isoindolin-1-one (S-isomer) | 2375482-51-0 | 99.5% | 516.59 Da | C31H28N6O2 | 50MG
BI-2852 is a small-molecule inhibitor that binds the KRAS switch I/II pocket and inhibits active, GTP-bound KRAS with nanomolar potency. It is intended for research use and is used as a tool compound to study KRAS-driven signaling, pERK modulation, and antiproliferative effects in KRAS-mutant cell models.
- Potent nanomolar inhibition of KRAS switch I/II pocket.
- Directly targets active GTP-bound KRAS to disrupt effector interactions.
- Suitable for in vitro studies of KRAS signaling and cell proliferation.
- High purity (>99%) suitable for biochemical and cell-based assays.
- Molecular formula C31H28N6O2 and molecular weight 516.59 Da.
- Available with supporting documentation, including COA and SDS.
Medchemexpress LLC HY-101971 10mg Medchemexpress, AZ PFKFB3 26 CAS:1704740-52-2 Purity:>98%
Medchemexpress, HY-101971 10mg AZ PFKFB3 26 CAS:1704740-52-2 AZ PFKFB3 26 is a potent and selective inhibitor of the metabolic kinase PFKFB3 with an IC50 of 23 nM. AZ PFKFB3 26 inhibits PFKFB1 and PFKFB2 with IC50s of 2.06 and 0.384 μM, respectively. Purity:>98% Medchemexpress has over 10000 novel life-science reagents, reference compounds, APIs and natural compounds for laboratory and scientific use. Other quantity can also be offered.
![Medchemexpress LLC Heptanoic acid, 7-[[(1,1-dimethylethoxy)carbonyl]amino]- | 60142-89-4 | HY-W012001 | >=98.0% | 245.32 | 100 G](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000454000-logo.png-250.jpg){kind=logo}
Medchemexpress LLC Heptanoic acid, 7-[[(1,1-dimethylethoxy)carbonyl]amino]- | 60142-89-4 | HY-W012001 | >=98.0% | 245.32 | 100 G
N-Boc-7-aminoheptanoic acid is a PROTAC linker used in the synthesis of PROTACs and other conjugation applications. It features an alkane chain with terminal carboxylic acid and Boc-protected amino groups. The terminal carboxylic acid can react with primary amine groups in the presence of activators like EDC or HATU to form a stable amide bond, and the Boc group can be deprotected under mild acidic conditions to yield the free amine.
- Utilized as a PROTAC linker
- Suitable for PROTAC synthesis
- Suitable for other conjugation applications
- Features an alkane chain with terminal carboxylic acid and Boc-protected amino groups
- Carboxylic acid reacts with primary amines for stable amide bond formation
- Boc group deprotects under mild acidic conditions to yield free amine